enGene Holdings Inc expected to post a loss of 56 cents a share - Earnings Preview

Reuters02-27

enGene Holdings Inc <engn.oq> expected to post a loss of 56 cents a share - Earnings Preview </engn.oq>

enGene Holdings Inc ENGN.OQ ENGN.O is expected to show no change in quarterly revenue when it reports results on March 2 (estimated) for the period ending January 31 2026
LSEG's mean analyst estimate for enGene Holdings Inc is for a loss of 56 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for enGene Holdings Inc is $25.50, about 154.2% above its last closing price of $10.03

Previous quarterly performance (using preferred earnings measure in US dollars).

QUARTER ENDING	STARMINESMARTESTIMATE®	LSEG IBES ESTIMATE	ACTUAL	BEAT, MET, MISSED	SURPRISE %
Oct. 31 2025	-0.57	-0.57	-0.73	Missed	-28.5
Jul. 31 2025	-0.51	-0.50	-0.57	Missed	-13.7
Apr. 30 2025	-0.53	-0.50	-0.51	Missed	-2.4
Jan. 31 2025	-0.36	-0.37	-0.48	Missed	-29.3
Oct. 31 2024	-0.39	-0.38	-0.34	Beat	10
Jul. 31 2024	-0.43	-0.37	-0.32	Beat	14.7
Apr. 30 2024	-0.26	-0.26	-0.38	Missed	-45

This summary was machine generated February 27 at 14:10 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2614497851?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-27 22:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614497851","market":"nz","top_or_hot":-1,"title":"enGene Holdings Inc  expected to post a loss of 56 cents a share - Earnings Preview","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>enGene Holdings Inc <engn.oq> expected to post a loss of 56 cents a share - Earnings Preview </engn.oq></title></head><body><ul><li><p>enGene Holdings Inc <span>ENGN.OQ</span> <span>ENGN.O</span> is expected to  show no change in quarterly revenue when it reports  results on March 2 (estimated) for the period ending January 31 2026</p></li><li></li><li><p>LSEG's mean analyst estimate for enGene Holdings Inc is for a loss of 56 cents per share. </p></li><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 11 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"  </p></li><li><p>The mean earnings estimate of analysts was unchanged in the last three months. </p></li><li><p>Wall Street's median 12-month price target for enGene Holdings Inc is $25.50, about 154.2% above its last closing price of $10.03</p></li></ul><p>Previous quarterly performance (using preferred earnings measure in US dollars). </p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>STARMINESMARTESTIMATE®</p></td><td><p>LSEG IBES ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td><td><p>SURPRISE %</p></td></tr><tr><td><p>Oct. 31 2025</p></td><td><p>-0.57</p></td><td><p>-0.57</p></td><td><p>-0.73</p></td><td><p>Missed</p></td><td><p>-28.5</p></td></tr><tr><td><p>Jul. 31 2025</p></td><td><p>-0.51</p></td><td><p>-0.50</p></td><td><p>-0.57</p></td><td><p>Missed</p></td><td><p>-13.7</p></td></tr><tr><td><p>Apr. 30 2025</p></td><td><p>-0.53</p></td><td><p>-0.50</p></td><td><p>-0.51</p></td><td><p>Missed</p></td><td><p>-2.4</p></td></tr><tr><td><p>Jan. 31 2025</p></td><td><p>-0.36</p></td><td><p>-0.37</p></td><td><p>-0.48</p></td><td><p>Missed</p></td><td><p>-29.3</p></td></tr><tr><td><p>Oct. 31 2024</p></td><td><p>-0.39</p></td><td><p>-0.38</p></td><td><p>-0.34</p></td><td><p>Beat</p></td><td><p>10</p></td></tr><tr><td><p>Jul. 31 2024</p></td><td><p>-0.43</p></td><td><p>-0.37</p></td><td><p>-0.32</p></td><td><p>Beat</p></td><td><p>14.7</p></td></tr><tr><td><p>Apr. 30 2024</p></td><td><p>-0.26</p></td><td><p>-0.26</p></td><td><p>-0.38</p></td><td><p>Missed</p></td><td><p>-45</p></td></tr></tbody></table><p>This summary was machine generated February 27 at 14:10 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>enGene Holdings Inc  expected to post a loss of 56 cents a share - Earnings Preview</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nenGene Holdings Inc  expected to post a loss of 56 cents a share - Earnings Preview\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-27 22:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>enGene Holdings Inc <engn.oq> expected to post a loss of 56 cents a share - Earnings Preview </engn.oq></title></head><body><ul><li><p>enGene Holdings Inc <span>ENGN.OQ</span> <span>ENGN.O</span> is expected to  show no change in quarterly revenue when it reports  results on March 2 (estimated) for the period ending January 31 2026</p></li><li></li><li><p>LSEG's mean analyst estimate for enGene Holdings Inc is for a loss of 56 cents per share. </p></li><li><p>The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 11 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"  </p></li><li><p>The mean earnings estimate of analysts was unchanged in the last three months. </p></li><li><p>Wall Street's median 12-month price target for enGene Holdings Inc is $25.50, about 154.2% above its last closing price of $10.03</p></li></ul><p>Previous quarterly performance (using preferred earnings measure in US dollars). </p><table><tbody><tr><td><p>QUARTER ENDING</p></td><td><p>STARMINESMARTESTIMATE®</p></td><td><p>LSEG IBES ESTIMATE </p></td><td><p>ACTUAL</p></td><td><p>BEAT, MET, MISSED</p></td><td><p>SURPRISE %</p></td></tr><tr><td><p>Oct. 31 2025</p></td><td><p>-0.57</p></td><td><p>-0.57</p></td><td><p>-0.73</p></td><td><p>Missed</p></td><td><p>-28.5</p></td></tr><tr><td><p>Jul. 31 2025</p></td><td><p>-0.51</p></td><td><p>-0.50</p></td><td><p>-0.57</p></td><td><p>Missed</p></td><td><p>-13.7</p></td></tr><tr><td><p>Apr. 30 2025</p></td><td><p>-0.53</p></td><td><p>-0.50</p></td><td><p>-0.51</p></td><td><p>Missed</p></td><td><p>-2.4</p></td></tr><tr><td><p>Jan. 31 2025</p></td><td><p>-0.36</p></td><td><p>-0.37</p></td><td><p>-0.48</p></td><td><p>Missed</p></td><td><p>-29.3</p></td></tr><tr><td><p>Oct. 31 2024</p></td><td><p>-0.39</p></td><td><p>-0.38</p></td><td><p>-0.34</p></td><td><p>Beat</p></td><td><p>10</p></td></tr><tr><td><p>Jul. 31 2024</p></td><td><p>-0.43</p></td><td><p>-0.37</p></td><td><p>-0.32</p></td><td><p>Beat</p></td><td><p>14.7</p></td></tr><tr><td><p>Apr. 30 2024</p></td><td><p>-0.26</p></td><td><p>-0.26</p></td><td><p>-0.38</p></td><td><p>Missed</p></td><td><p>-45</p></td></tr></tbody></table><p>This summary was machine generated February 27 at 14:10 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260227:nL8N3ZN1PA:1","article_id":"2614497851","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2614497851","pubTimestamp":1772201406,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"enGene Holdings Inc  expected to post a loss of56cents a share - Earnings Preview enGene Holdings Inc ENGN.OQ ENGN.O is expected to  show no change in quarterly revenue when it reports  results on Mar","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ENGN":"ENGENE HOLDINGS INC"},"translate_title":"enGene Holdings Inc预计每股亏损56美分-收益预览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ENGN":0.9},"content_text":"enGene Holdings Inc  expected to post a loss of 56 cents a share - Earnings Preview enGene Holdings Inc ENGN.OQ ENGN.O is expected to  show no change in quarterly revenue when it reports  results on March 2 (estimated) for the period ending January 31 2026LSEG's mean analyst estimate for enGene Holdings Inc is for a loss of 56 cents per share. The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 11 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"  The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for enGene Holdings Inc is $25.50, about 154.2% above its last closing price of $10.03Previous quarterly performance (using preferred earnings measure in US dollars). QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATE ACTUALBEAT, MET, MISSEDSURPRISE %Oct. 31 2025-0.57-0.57-0.73Missed-28.5Jul. 31 2025-0.51-0.50-0.57Missed-13.7Apr. 30 2025-0.53-0.50-0.51Missed-2.4Jan. 31 2025-0.36-0.37-0.48Missed-29.3Oct. 31 2024-0.39-0.38-0.34Beat10Jul. 31 2024-0.43-0.37-0.32Beat14.7Apr. 30 2024-0.26-0.26-0.38Missed-45This summary was machine generated February 27 at 14:10 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,preview","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2614497851","isCrawlerRequest":true}